1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123(8): 933-944.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50(22): 2173-2195.
3. Yu J, Christman KL, Chin E, Sievers RE, Saeed M, Lee RJ. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2009; 137(1): 180-187.
4. Lee RJ, Hinson A, Bauernschmitt R, Matschke K, Fang Q, Mann DL, et al. The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results. Int J Cardiol. 2015; 199: 18-24.
5. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA. 2011; 306(15): 1669-1678.
6. Nelson DM, Ma Z, Fujimoto KL, Hashizume R, Wagner WR. Intramyocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater. 2011; 7(1): 1-15.
7. Choe G, Kim SW, Park J, Park J, Kim S, Kim YS, et al. Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels: Mesenchymal stem cell encapsulation and regeneration of infarcted hearts. Biomaterials. 2019; 225: 119513.
8. Müller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002; 34(2): 107-116.
9. Müller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006; 41(5): 876-884.
10. Zhang H, Song P, Tang Y, Zhang Xl, Zhao Sh, Wei Yj, et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J Thorac Cardiovasc Surg. 2007; 134(5): 1234-1240.
11. Sabbah HN, Wang M, Gupta RC, Rastogi S, Ilsar I, Sabbah MS, et al. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail. 2013; 1(3): 252-258.
12. Roshanbinfar K, Hilborn J, Varghese OP, Oommen OP. Injectable and thermoresponsive pericardial matrix derived conductive scaffold for cardiac tissue engineering. RSC Adv. 2017; 7(51): 31980-31988.
13. Cui H, Liu Y, Cheng Y, Zhang Z, Zhang P, Chen X, et al. In vitro study of electroactive tetraaniline-containing thermosensitive hydrogels for cardiac tissue engineering. Biomacromolecules. 2014;15(4): 1115-1123.
14. Lee WC, Lim CH, Shi H, Tang LA, Wang Y, Lim CT, et al. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano. 2011; 5(9): 7334-7341.
15. Park J, Kim YS, Ryu S, Kang WS, Park S, Han J, et al. Graphene potentiates the myocardial repair efficacy of mesenchymal stem cells by stimulating the expression of angiogenic growth factors and gap junction protein. Adv Funct Mater. 2015; 25(17): 2590-2600.
16. Karimi Hajishoreh N, Baheiraei N, Naderi N, Salehnia M. Reduced graphene oxide facilitates biocompatibility of alginate for cardiac repair. J Bioact Compat Polym. 2020; 35(4-5): 363-377.
17. Naderi N, Hemmatinafar M, Gaeini AA, Bahramian A, Ghardashi- Afousi A, Kordi MR, et al. High-intensity interval training increase GATA4, CITED4 and c-Kit and decreases C/EBPβ in rats after myocardial infarction. Life Sci. 2019; 221: 319-326.
18. Shams Mofarahe Z, Ghaffari Novin M, Salehnia M. Folliculogenesis-associated genes expression in human vitrified ovarian tissue after xenotransplantation in γ-irradiated mice. Cell J. 2020; 22(3): 350-357.
19. Ye Z, Zhou Y, Cai H, Tan W. Myocardial regeneration: roles of stem cells and hydrogels. Adv Drug Deliv Rev. 2011; 63(8): 688-697.
20. Ruvinov E, Cohen S. Alginate biomaterial for the treatment of myocardial infarction: progress, translational strategies, and clinical outlook: from ocean algae to patient bedside. Adv Drug Deliv Rev. 2016; 96: 54-76.
21. Meng D, Diao C, Liang L. Engineering an alginate/β-glycerophosphate/dextran injectable hydrogel-delivery for cardiac
therapies after acute myocardial infarctions. Mater Express. 2021; 11(6): 846-853.
22. Choy JS, Leng S, Acevedo-Bolton G, Shaul S, Fu L, Guo X, et al. Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine. Int J Cardiol. 2018; 255: 129-135.
23. Qiu Y, Wang Z, Owens AC, Kulaots I, Chen Y, Kane AB, et al. Antioxidant chemistry of graphene-based materials and its role in oxidation protection technology. Nanoscale. 2014; 6(20): 11744- 11755.
24. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829): 701-705.
25. Shin SR, Zihlmann C, Akbari M, Assawes P, Cheung L, Zhang K, et al. Reduced graphene oxide-gelma hybrid hydrogels as scaffolds for cardiac tissue engineering. Small. 2016; 12(27): 3677-3689.
26. Zhao G, Feng Y, Xue L, Cui M, Zhang Q, Xu F, et al. Anisotropic conductive reduced graphene oxide/silk matrices promote postinfarction myocardial function by restoring electrical integrity. Acta Biomater. 2022; 139: 190-203.